Investor List:

Top Diagnostics Series B Investors in San Francisco Bay Area (48)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Diagnostics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures
Geoffrey Smith
Digitalis Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Manufacturing (Series B), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Jason G., Investor at B Capital Group
Jason G.
B Capital Group·Investor
Sweet spot: $25.0M
Range: $25.0M - $60.0M
Investors in SF Bay Area (CA)
Photo of Megan Kotrappa, Investor at B Capital Group
Megan Kotrappa
B Capital Group·Investor
Sweet spot: $25.0M
Range: $25.0M - $60.0M
Investors in San Francisco (CA)
Photo of Ling Wong, Managing Partner at Highbury Group
Ling Wong
Highbury Group·Managing Partner
Sweet spot: $10.0M
Range: $500K - $50.0M
Investors in San Francisco (CA), Investors in Seattle (WA)
Investors in Consumer Health (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Series B), Investors in Investors who were founders (Other Lists), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in AI (Series A)
Photo of Jenny Rooke, Managing Director at Genoa Ventures
Jenny Rooke
Genoa Ventures·Managing Director
Sweet spot: $2.0M
Range: $250K - $10.0M
Investors in San Francisco (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)
Photo of Cris De Luca, Partner at Sanofi Ventures
Cris De Luca
Sweet spot: $10.0M
Range: $2.0M - $20.0M
Investors in Paris (France), Investors in Israel, Investors in New York (NY), Investors in Europe, Investors in San Francisco (CA), Investors in Cambridge (MA)
Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Generative Tech/AI (Series B), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in IoT (Series B), Investors in Medical Devices (Series A), Investors in IoT (Series A), Investors in Pharmaceuticals (Series B), Investors in Diverse Investors (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Investors who were founders (Other Lists), Investors in Health IT (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Israel (Other Lists), Investors in AI (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in AI (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in AI (Series A), Investors in Consumer Health (Series A), Investors in IoT (Series A), Investors in IoT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in IoT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in IoT (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in AI (Series B), Investors in Pharmaceuticals (Series A), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in AI (Series B), Investors in IoT (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in IoT (Series B), Investors in IoT (Series B), Investors in IoT (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A)
Photo of Claes Wahlestedt, PhD, MD, Vice President at Pacific Biosciences
Claes Wahlestedt, PhD, MD
Pacific Biosciences·Vice President
Sweet spot: $10.0M
Range: $1M - $20.0M
Investors in Boston (MA), Investors in San Diego (CA), Investors in New York (NY), Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Investors in Drug Delivery (Series A), Investors in Drug Delivery (Pre-seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Pre-seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Series A), Investors in AI (Seed), Investors in AI (Pre-seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Pre-seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series B), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in AI (Series B), Investors in Diagnostics (Seed), Investors in AI (Pre-seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Series B), Investors in Drug Delivery (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Pre-seed), Investors in AI (Seed), Investors in Consumer Health (Seed), Investors in AI (Series A), Investors in Digital Health (Seed), Investors in Generative Tech/AI (Pre-seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series B), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Series B), Investors in Pharmaceuticals (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Generative Tech/AI (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in AI (Series A), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Consumer Health (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Diagnostics (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series B), Investors in Digital Health (Pre-seed), Investors in Consumer Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series B), Investors in AI (Series A), Investors in Health IT (Series A), Investors in BioTech (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in BioTech (Pre-seed), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in AI (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Series B), Investors in Diagnostics (Seed), Investors in Consumer Health (Pre-seed), Investors in Pharmaceuticals (Series B), Investors in Drug Delivery (Series B), Investors in Generative Tech/AI (Seed), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Pre-seed), Investors in Boston / New England (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Pre-seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Generative Tech/AI (Series B), Investors in Drug Delivery (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Drug Delivery (Seed), Investors in Diverse Investors (Other Lists), Investors in Digital Health (Series A), Investors in Drug Delivery (Series B), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Generative Tech/AI (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Digital Health (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Series A), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Diagnostics (Seed), Investors in Investors who were founders (Other Lists), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in AI (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Series B), Investors in AI (Series B), Investors in AI (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Consumer Health (Series A)
Photo of Jarret Glasscock, Venture Partner at Pioneer Fund
Jarret Glasscock
Pioneer Fund·Venture Partner
Sweet spot: $250K
Range: $200K - $300K
Investors in SF Bay Area (CA)